As of the time of writing, both agents remain in clinical development and have not received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA)
Skin tissue particularly keratinocytes, melanocytes, and dermal immune cells expresses MC1R, and NF-B dysregulation underlies a range of inflammatory skin conditions
BPC-157 has been shown to be particularly effective for healing injuries that typically take a long time to recover, like tendon and ligament damage, where the bodys natural repair process is often slow
Company : Healthletic Return Address : 27 Old Gloucester Street London WC1N 3AX United Kingdom Email : [email protected] Disclaimer & Disclosure The information provided in this article is intended for general informational and educational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice, diagnosis, or treatment